Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Wu

Showing results (201-210 of 205) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 205 results.
Clinical Pharmacology and Therapeutics|June 18, 2015
Pentoxifylline Decreases Dialysis Risk in Patients With Advanced Chronic Kidney DiseaseP-C Wu, C-J Wu, C-J Lin, et al.
Surgery|November 24, 1999
Isolated hepatic perfusion for lapine liver metastases: impact of hyperthermia on permeability of tumor neovasculatureM F Gnant, L A Noll, R E Terrill, et al.
Hepatology (Baltimore, Md.)|June 8, 2001
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapyN W Leung, C L Lai, T T Chang, et al.
The New England Journal of Medicine|July 9, 1998
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study GroupC L Lai, R N Chien, N W Leung, et al.
Cell Death and Differentiation|January 30, 2016
Aiolos collaborates with Blimp-1 to regulate the survival of multiple myeloma cellsK-H Hung, S-T Su, C-Y Chen, et al.
Pageof 21

Showing results (201-210 of 205) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 205 results.
Clinical Pharmacology and Therapeutics|June 18, 2015
Pentoxifylline Decreases Dialysis Risk in Patients With Advanced Chronic Kidney DiseaseP-C Wu, C-J Wu, C-J Lin, et al.
Surgery|November 24, 1999
Isolated hepatic perfusion for lapine liver metastases: impact of hyperthermia on permeability of tumor neovasculatureM F Gnant, L A Noll, R E Terrill, et al.
Hepatology (Baltimore, Md.)|June 8, 2001
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapyN W Leung, C L Lai, T T Chang, et al.
The New England Journal of Medicine|July 9, 1998
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study GroupC L Lai, R N Chien, N W Leung, et al.
Cell Death and Differentiation|January 30, 2016
Aiolos collaborates with Blimp-1 to regulate the survival of multiple myeloma cellsK-H Hung, S-T Su, C-Y Chen, et al.
Pageof 21